Nationwide Program Locations (Based at ASU Edson College of Nursing and Health Innovation)
Phoenix, Arizona, 85004, United States
NCT Number: NCT03144921
EPIC II (Early-Stage Partners in Care) is a research project designed to assist people with early-stage memory loss and their care partners by providing early-stage related education and skill-training sessions, held via Zoom, designed to reduce stress, enhance well-being, manage challenges, and plan for the future. Researchers will gather feedback from individuals about their experience to continue to improve programs for early-stage memory loss.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Phoenix, Arizona, 85004, United States
The purpose of this study is to help early-stage individuals who have early-stage memory loss or early stage dementia and their current or future care partners by providing education and skill-training programs, held via Zoom, designed to reduce stress and distress, increase well-being and quality of life, and plan for the future. About 160 early-stage dyads (person with early-stage dementia and his/her care partner) will be enrolled across the United States through Arizona State University.
People who decide to voluntarily participate in this program, will be asked to:
Each person will receive up to $45 for completing all follow-up interviews, or $20- 25 for each interview completed. All participants are offered the EPIC sessions shortly after their first interview or shortly after their 3-month interview. Some participants will also attend an additional free education workshop within one month of the initial assessment.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
DYAD INCLUSION CRITERIA:
EP INCLUSION CRITERIA:
EP EXCLUSION CRITERIA:
This protocol is a minimal risk care values clarification /care planning and psychoeducational skills training intervention, delivered as a workshop series plus one in-home session for people in the early stages of memory loss and their care partner together.
Time frame: Assessments T1-T3 to be conducted over span of six months
Examine the efficacy of the EPIC intervention as compared with a Wait List Comparison condition by looking at the change over time in the Positive and Negative Affect Scales (Dementia Quality of Life Instrument).
Time frame: Assessments T1-T3 to be conducted over span of six months
Assess EP Quality of life and CPs perception of EPs Quality of life by looking at the change over time in the Quality of Life Measure in Dementia.
Time frame: Assessments T1-T3 to be conducted over span of six months
Assess the knowledge of, use of, and satisfaction with a variety of services (for example, respite, support groups, case management, referral services) relevant to people with dementia and their care partners by looking at the change over time.
Time frame: Assessments T1-T3 to be conducted over span of six months
Assess communication by looking at the change over time in the Dyadic Relationship Scale and Emotional Intimacy Disruptive Behavior Scale.
Time frame: Assessments T1-T3 to be conducted over span of six months
Assess EP and CP perceptions of how well prepared they feel for addressing future care needs by looking at the change over time in the Care Partners Preparedness Scale (modified).
Time frame: T1 - T2 Assessments (Baseline to 3 months)
Based on Quality of Life Adjusted Years for the EPs and hours providing care for CPs, conduct a cost benefit analysis to explicitly indicate whether benefits of the EPIC program outweigh costs by looking at the change over time.
Arizona State University
Other
EPIC: A Group-based Intervention for Early-stage AD Dyads in Diverse Communities
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07294586
Alzheimer Disease, Brain Diseases
Colmar, Alsace, France
View Trial DetailsNCT03901456
Alzheimer Disease, Brain Diseases
Minneapolis, Minnesota, United States
View Trial DetailsNCT05661084
Alzheimer Disease, Brain Diseases
Boston, Massachusetts, United States
View Trial DetailsNCT05550727
Alzheimer Disease, Brain Diseases
Minneapolis, Minnesota, United States
View Trial Details